Making cold malignant pleural effusions hot: driving novel immunotherapies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Making cold malignant pleural effusions hot: driving novel immunotherapies
Authors
Keywords
-
Journal
OncoImmunology
Volume -, Issue -, Pages 1-24
Publisher
Informa UK Limited
Online
2019-01-23
DOI
10.1080/2162402x.2018.1554969
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activated Naïve B Cells Promote Development of Malignant Pleural Effusion by Different Regulation of TH1 and TH17 Response
- (2018) Xiu-Zhi Wu et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with Esophageal Cancer
- (2018) Yusuke Ishibashi et al. ANNALS OF SURGICAL ONCOLOGY
- Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
- (2018) Cécile Le Page et al. BMC CANCER
- Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer
- (2018) Lourdes Barrera et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Preoperative increased systemic immune-inflammation index predicts poor prognosis in patients with operable non-small cell lung cancer
- (2018) Yongyin Gao et al. CLINICA CHIMICA ACTA
- Aberrant Lck Signal via CD28 Costimulation Augments Antigen-Specific Functionality and Tumor Control by Redirected T Cells with PD-1 Blockade in Humanized Mice
- (2018) Pratiksha Gulati et al. CLINICAL CANCER RESEARCH
- Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non–Small-Cell Lung Cancer
- (2018) Alona Zer et al. Clinical Lung Cancer
- CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises
- (2018) Bing Tong et al. Future Oncology
- A Tumor Cell-Intrinsic Yin-Yang Determining Immune Evasion
- (2018) Brendan Horton et al. IMMUNITY
- Concentrations of SP-A and HSP70 are associated with polarization of macrophages in pleural effusions of non-small cell lung cancer
- (2018) Mariusz Kaczmarek et al. IMMUNOBIOLOGY
- Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T
- (2018) Dok Yoon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neutrophil-lymphocyte ratio predicts recurrence in patients with resected stage 1 non-small cell lung cancer
- (2018) Shinjiro Mizuguchi et al. Journal of Cardiothoracic Surgery
- Extracellular DNA promotes colorectal tumor cell survival after cytotoxic chemotherapy
- (2018) Reginald Anunobi et al. JOURNAL OF SURGICAL RESEARCH
- Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies
- (2018) Stefan Kiesgen et al. Journal of Thoracic Oncology
- Malignant pleural effusions: will PROMISE make its name true?
- (2018) Paul Baas et al. LANCET ONCOLOGY
- Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis
- (2018) Ioannis Psallidas et al. LANCET ONCOLOGY
- Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion
- (2018) Charu Aggarwal et al. MOLECULAR THERAPY
- Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion
- (2018) Rahul Bhatnagar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion
- (2018) Jeong Uk Lim et al. PLoS One
- An Observational Study Evaluating the Performance of LENT Score in the Selected Population of Malignant Pleural Effusion from Lung Adenocarcinoma in Singapore
- (2018) John Abisheganaden et al. RESPIRATION
- Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)
- (2018) Alberto Farolfi et al. Targeted Oncology
- Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers
- (2018) Ivana Catacchio et al. Translational Oncology
- Bi-specific ligand-controlled chimeric antigen receptor T-cell therapy for non-small cell lung cancer
- (2018) Wenqi Chu et al. BioScience Trends
- Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis
- (2018) Ross A. Soo et al. Oncotarget
- EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
- (2018) Jiyoul Yang et al. Cancer Research and Treatment
- Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization
- (2018) Annalisa Bosi et al. Journal of Immunology Research
- Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions
- (2018) Joanna Budna et al. Journal of Immunology Research
- A comparison between two types of indwelling pleural catheters for management of malignant pleural effusions
- (2018) Sushilkumar Satish Gupta et al. Journal of Thoracic Disease
- Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial
- (2018) Sanjeevan Muruganandan et al. Lancet Respiratory Medicine
- The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M(IL-4) Macrophages in Response to Mycobacterium tuberculosis
- (2018) Geanncarlo Lugo-Villarino et al. Frontiers in Immunology
- Post-treatment changes in hematological parameters predict response to nivolumab monotherapy in non-small cell lung cancer patients
- (2018) Monica Khunger et al. PLoS One
- Tumor mutational burden is a determinant of immune-mediated survival in breast cancer
- (2018) Alexandra Thomas et al. OncoImmunology
- Diesel exhaust particles induce autophagy and citrullination in Normal Human Bronchial Epithelial cells
- (2018) Tania Colasanti et al. Cell Death & Disease
- Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Lung Cancers
- (2018) Michael Offin et al. CLINICAL CANCER RESEARCH
- Regulatory T cells in malignant pleural effusions subsequent to lung carcinoma and their impact on the course of the disease
- (2017) J. Budna et al. IMMUNOBIOLOGY
- Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer
- (2017) Ramaswamy Govindan et al. JOURNAL OF CLINICAL ONCOLOGY
- LAG-3 Protein Expression in Non–Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes
- (2017) Yayi He et al. Journal of Thoracic Oncology
- PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer
- (2017) Hui Yu et al. Journal of Thoracic Oncology
- Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer
- (2017) Yu-Suo Tong et al. Journal of Translational Medicine
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study
- (2017) Matthew D Hellmann et al. LANCET ONCOLOGY
- Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
- (2017) Aaron M. Goodman et al. MOLECULAR CANCER THERAPEUTICS
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR T-cell therapy for lung cancer and malignant pleural mesothelioma
- (2017) Masha Zeltsman et al. Translational Research
- MUC1 downregulation inhibits non‑small cell lung cancer progression in human cell lines
- (2017) Tao Xu et al. Experimental and Therapeutic Medicine
- Neutrophils dominate the immune cell composition in non-small cell lung cancer
- (2017) Julia Kargl et al. Nature Communications
- Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
- (2017) Zuqiang Liu et al. Nature Communications
- Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients
- (2017) Elly Marcq et al. Oncotarget
- APRIL promotes non-small cell lung cancer growth and metastasis by targeting ERK1/2 signaling
- (2017) Hengli Dou et al. Oncotarget
- Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies
- (2017) Jiayin Shen et al. Oncotarget
- PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells
- (2017) Xinru Wei et al. OncoImmunology
- IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid
- (2017) D. Croxatto et al. OncoImmunology
- Management of malignant pleural effusion: challenges and solutions
- (2017) Erika Penz et al. Cancer Management and Research
- Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)
- (2017) et al. Cancers
- Extended Tumor Control after Dendritic Cell Vaccination with Low-Dose Cyclophosphamide as Adjuvant Treatment in Patients with Malignant Pleural Mesothelioma
- (2016) Robin Cornelissen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Harnessing the Power of the Host: Improving Dendritic Cell Vaccines for Malignant Pleural Mesothelioma
- (2016) Tobias Peikert et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Upregulation of soluble B7-H3 in NSCLC-derived malignant pleural effusion: A potential diagnostic biomarker correlated with NSCLC staging
- (2016) Liwen Chen et al. CLINICA CHIMICA ACTA
- Interleukin-2 reverses CD8+T cell exhaustion in clinical malignant pleural effusion of lung cancer
- (2016) C. Y. Hu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Phenotyping malignant pleural effusions
- (2016) Macy M.S. Lui et al. CURRENT OPINION IN PULMONARY MEDICINE
- Should anti-mesothelin therapies be explored in lung cancer?
- (2016) Anish Thomas Expert Review of Anticancer Therapy
- Impaired T cell function in malignant pleural effusion is caused by TGF-β derived predominantly from macrophages
- (2016) Lifeng Li et al. INTERNATIONAL JOURNAL OF CANCER
- Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway
- (2016) Tao Yin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
- (2016) Scott Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage-Mediated T Cell Suppression
- (2016) Lysanne A. Lievense et al. Journal of Thoracic Oncology
- Malignant Mesothelioma Effusions Are Infiltrated by CD3 + T Cells Highly Expressing PD-L1 and the PD-L1 + Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti–PD-L1 Antibody Avelumab
- (2016) Swati Khanna et al. Journal of Thoracic Oncology
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies
- (2016) David T. Rodgers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Malignant pleural fluid from mesothelioma has potent biological activities
- (2016) Hui Min Cheah et al. RESPIROLOGY
- Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer
- (2016) Kaichao Feng et al. Science China-Life Sciences
- Perspectives from man’s best friend: National Academy of Medicine’s Workshop on Comparative Oncology
- (2016) Amy K. LeBlanc et al. Science Translational Medicine
- Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment
- (2016) Ramin Lotfi et al. TRANSFUSION MEDICINE AND HEMOTHERAPY
- EGFR as a Pharmacological Target in EGFR -Mutant Non-Small-Cell Lung Cancer: Where Do We Stand Now?
- (2016) E-->-E -->Ke et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Concordance of folate receptor-α expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients
- (2016) Leonora S.F. Boogerd et al. Oncotarget
- Neutrophil-Derived IL-1β Impairs the Efficacy of NF-κB Inhibitors against Lung Cancer
- (2016) Allyson G. McLoed et al. Cell Reports
- Increased expression of A Proliferation-inducing Ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: a possible link between COPD and lung cancer?
- (2016) Francesca Polverino et al. MULTIDISCIPLINARY RESPIRATORY MEDICINE
- Curative Effects of Dendritic Cells Combined with Cytokine-Induced Killer Cells in Patients with Malignant Pericardial Effusion
- (2016) Hongmin Wang et al. MEDICAL SCIENCE MONITOR
- De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute
- (2016) I. Mellman et al. Cancer Immunology Research
- Priming of neutrophils toward NETosis promotes tumor growth
- (2016) Mélanie Demers et al. OncoImmunology
- Targeting inflammasome/IL-1 pathways for cancer immunotherapy
- (2016) Beichu Guo et al. Scientific Reports
- DAMPs, ageing, and cancer: The ‘DAMP Hypothesis’
- (2015) Jin Huang et al. AGEING RESEARCH REVIEWS
- Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma Is an Effective and Safe Cytoreductive Surgery in the Elderly
- (2015) Trevor Williams et al. ANNALS OF THORACIC SURGERY
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion
- (2015) Fei Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Toll-like receptor 4 signaling inhibits malignant pleural effusion by altering Th1/Th17 responses
- (2015) Qian-Qian Xu et al. CELL BIOLOGY INTERNATIONAL
- Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: A meta-analysis
- (2015) Y Yin et al. Clinics
- Mortality among patients with pleural effusion undergoing thoracentesis
- (2015) Erin M. DeBiasi et al. EUROPEAN RESPIRATORY JOURNAL
- Mast cells mediate malignant pleural effusion formation
- (2015) Anastasios D. Giannou et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
- (2015) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- The pharmacology of second-generation chimeric antigen receptors
- (2015) Sjoukje J. C. van der Stegen et al. NATURE REVIEWS DRUG DISCOVERY
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluating early administration of the hydroxymethylglutaryl-CoA reductase inhibitor simvastatin in the prevention and treatment of delirium in critically ill ventilated patients (MoDUS trial): study protocol for a randomized controlled trial
- (2015) Annalisa Casarin et al. Trials
- High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis
- (2015) Anish Thomas et al. Oncotarget
- Important prognostic factors for survival in patients with malignant pleural effusion
- (2015) Mauro Musa Zamboni et al. BMC Pulmonary Medicine
- Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study
- (2015) Luana Calabrò et al. Lancet Respiratory Medicine
- Interplay of Th1 and Th17 Cells in Murine Models of Malignant Pleural Effusion
- (2014) Hua Lin et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis
- (2014) Katja Hattar et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Talc Pleurodesis Through Indwelling Pleural Catheters for Malignant Pleural Effusions
- (2014) Liju Ahmed et al. CHEST
- Catheter Tract Metastasis Associated With Indwelling Pleural Catheters
- (2014) Rajesh Thomas et al. CHEST
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
- (2014) B. Hu et al. CLINICAL CANCER RESEARCH
- Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) Maintenance as Monotherapy or in Combination With Bevacizumab (BEV) for Non-Small Cell Lung Cancer (NSCLC) Previously Treated With Chemotherapy
- (2014) N.A. Rizvi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Complexity of Danger: The Diverse Nature of Damage-associated Molecular Patterns
- (2014) Liliana Schaefer JOURNAL OF BIOLOGICAL CHEMISTRY
- miR141-CXCL1-CXCR2 Signaling-Induced Treg Recruitment Regulates Metastases and Survival of Non-Small Cell Lung Cancer
- (2014) M. Lv et al. MOLECULAR CANCER THERAPEUTICS
- Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score
- (2014) Amelia O Clive et al. THORAX
- Protocol of the Australasian Malignant Pleural Effusion (AMPLE) trial: a multicentre randomised study comparing indwelling pleural catheter versus talc pleurodesis
- (2014) Edward T H Fysh et al. BMJ Open
- Defect in recruiting effector memory CD8+T-cells in malignant pleural effusions compared to normal pleural fluid
- (2013) Arnaud Scherpereel et al. BMC CANCER
- Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma
- (2013) S. S. Kachala et al. CLINICAL CANCER RESEARCH
- Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
- (2013) Jonathan Cools-Lartigue et al. JOURNAL OF CLINICAL INVESTIGATION
- At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy
- (2013) Margaret K. Callahan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
- (2013) Andrew M. Intlekofer et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusions
- (2013) Elizabeth Ann T. Lieser et al. LUNG CANCER
- Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion
- (2013) NAN DU et al. ONCOLOGY REPORTS
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Strange attractors: DAMPs and autophagy link tumor cell death and immunity
- (2013) W Hou et al. Cell Death & Disease
- Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
- (2013) G. L. Beatty et al. Cancer Immunology Research
- Dendritic Cells: Master Regulators of the Immune Response
- (2013) I. Mellman Cancer Immunology Research
- HMGB1: The Central Cytokine for All Lymphoid Cells
- (2013) Guanqiao Li et al. Frontiers in Immunology
- NK cells from malignant pleural effusions are potent antitumor effectors
- (2013) Paola Vacca et al. OncoImmunology
- Quality of Life After Radical Pleurectomy Decortication for Malignant Pleural Mesothelioma
- (2012) Nathan M. Mollberg et al. ANNALS OF THORACIC SURGERY
- Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
- (2012) Ulf Petrausch et al. BMC CANCER
- The roles of mast cells in anticancer immunity
- (2012) Dyana K. Dalton et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer Cell Secretion of the DAMP Protein HMGB1 Supports Progression in Malignant Mesothelioma
- (2012) S. Jube et al. CANCER RESEARCH
- TLR2 in Pleural Fluid Is Modulated by Talc Particles during Pleurodesis
- (2012) Karolina Jankovicova et al. Clinical & Developmental Immunology
- Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1
- (2012) D. S. Chen et al. CLINICAL CANCER RESEARCH
- NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation
- (2012) Paola Vacca et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- PAMPs and DAMPs: signal 0s that spur autophagy and immunity
- (2012) Daolin Tang et al. IMMUNOLOGICAL REVIEWS
- Effect of an Indwelling Pleural Catheter vs Chest Tube and Talc Pleurodesis for Relieving Dyspnea in Patients With Malignant Pleural Effusion
- (2012) Helen E. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prognostic Impact of Malignant Pleural Effusion at Presentation in Patients with Metastatic Non–Small-Cell Lung Cancer
- (2012) Daniel Morgensztern et al. Journal of Thoracic Oncology
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression
- (2012) Xin Gao et al. PLoS One
- Macrophages in malignant pleural effusions – alternatively activated tumor associated macrophages
- (2012) Mariusz Kaczmarek et al. Wspolczesna Onkologia-Contemporary Oncology
- B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
- (2011) J. N. Kochenderfer et al. BLOOD
- Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway
- (2011) Heriberto Prado-Garcia et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Toll-like receptors
- (2011) Eva Marie Y. Moresco et al. CURRENT BIOLOGY
- Non-small Cell Lung Cancer Induces an Immunosuppressive Phenotype of Dendritic Cells in Tumor Microenvironment by Upregulating B7-H3
- (2011) Thomas Schneider et al. Journal of Thoracic Oncology
- Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
- (2011) Tom Treasure et al. LANCET ONCOLOGY
- Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy
- (2011) Antonio Di Stasi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Staging of patients after extrapleural pneumonectomy for malignant pleural mesothelioma - institutional review and current update
- (2011) C. Cao et al. Interactive Cardiovascular and Thoracic Surgery
- Consolidative Dendritic Cell-based Immunotherapy Elicits Cytotoxicity against Malignant Mesothelioma
- (2010) Joost P. Hegmans et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusions
- (2010) Elisabetta Pace et al. EUROPEAN JOURNAL OF CANCER
- T-cell exhaustion: characteristics, causes and conversion
- (2010) John S. Yi et al. IMMUNOLOGY
- Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases
- (2010) Nikolaos Barbetakis et al. Journal of Cardiothoracic Surgery
- Endogenous ligands of TLR2 and TLR4: agonists or assistants?
- (2010) Clett Erridge JOURNAL OF LEUKOCYTE BIOLOGY
- Phase I Trial of Intrapleural Docetaxel Administered Through an Implantable Catheter in Subjects with a Malignant Pleural Effusion
- (2010) David R. Jones et al. Journal of Thoracic Oncology
- Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010
- (2010) M. E. Roberts et al. THORAX
- CCL22 Recruits CD4-positive CD25-positive Regulatory T Cells into Malignant Pleural Effusion
- (2009) X.-J. Qin et al. CLINICAL CANCER RESEARCH
- LAG-3 Regulates Plasmacytoid Dendritic Cell Homeostasis
- (2009) C. J. Workman et al. JOURNAL OF IMMUNOLOGY
- Symptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesothelioma
- (2009) Vincenzo Ambrogi et al. JOURNAL OF SURGICAL ONCOLOGY
- Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication
- (2009) Xiao-Song Zhong et al. MOLECULAR THERAPY
- Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
- (2009) C. Carpenito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Innate immune responses in murine pleural mesothelial cells: Toll-like receptor-2 dependent induction of β-defensin-2 by staphylococcal peptidoglycan
- (2008) Tajamul Hussain et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions
- (2008) Dennis B. Cornfield et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion
- (2008) G-N. Liu et al. EUROPEAN RESPIRATORY JOURNAL
- Emerging paradigms in the management of malignant pleural effusions
- (2008) Ghulam Khaleeq et al. RESPIRATORY MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search